- Joined
- Jan 10, 2008
- Messages
- 3,581
- Reaction score
- 11
http://www.bmj.com/content/344/bmj.e4212
"High reprint orders in medical journals and pharmaceutical industry funding: case-control study."
Comment from former BMJ editor:
http://www.bmj.com/content/344/bmj.e4212/rr/592345
Medical journals make lots of profit from pharma companies ordering reprints of published articles. Perhaps there's nothing wrong with that, or perhaps these journals are a little more motivated to publish studies they feel will generate reprint orders and $$$.
And how about the refusal of American publishers to release any data on reprint orders and associated revenues. Hmmm....
"a single Lancet paper with a similar sale of 835,100 reprints, amounted to a journal income of around US $2.4 million."
"High reprint orders in medical journals and pharmaceutical industry funding: case-control study."
Comment from former BMJ editor:
http://www.bmj.com/content/344/bmj.e4212/rr/592345
Medical journals make lots of profit from pharma companies ordering reprints of published articles. Perhaps there's nothing wrong with that, or perhaps these journals are a little more motivated to publish studies they feel will generate reprint orders and $$$.
And how about the refusal of American publishers to release any data on reprint orders and associated revenues. Hmmm....
"a single Lancet paper with a similar sale of 835,100 reprints, amounted to a journal income of around US $2.4 million."